Is Syros Pharmaceuticals Inc (SYRS) Stock Near the Top of the Biotechnology Industry?

Friday, December 18, 2020 1:53 PM | InvestorsObserver Analysts

The 51 rating InvestorsObserver gives to Syros Pharmaceuticals Inc (SYRS) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 60 percent of stocks in the Biotechnology industry, SYRS’s 51 overall rating means the stock scores better than 51 percent of all stocks.

Overall Score - 51
SYRS has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on SYRS!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 51 means the stock is more attractive than 51 percent of stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Syros Pharmaceuticals Inc Stock Today?

Syros Pharmaceuticals Inc (SYRS) stock is higher by 9.3% while the S&P 500 has fallen -0.66% as of 1:34 PM on Friday, Dec 18. SYRS has risen $1.03 from the previous closing price of $11.07 on volume of 392,085 shares. Over the past year the S&P 500 has gained 15.37% while SYRS has risen 94.53%. SYRS lost -$1.65 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Syros Pharmaceuticals Inc (SYRS) Stock.

Share this article:

Related Companies

You May Also Like

Related Articles

Sector Update: Health Care Stocks Fading Near Tuesday Bell

Sector Update: Health Care

Pulse Biosciences Inc (PLSE) is down -8.41% in a Week, Should You Hold?

How Does iTeos Therapeutics Inc (ITOS) Stock Rank on Wall Street Tuesday?

Does Akouos Inc (AKUS) Have What it Takes to be in Your Portfolio Tuesday?

Analyst Rating: Will Arcturus Therapeutics Holdings Inc (ARCT) Stock Lead the Market?

Related Companies